TrialBMC cancer2023

The CHASIT study: sequential chemo-immunotherapy in patients with locally advanced urothelial cancer - a non-randomized phase II clinical trial.

V C Rutten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.